Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia

R. Mertelsmann, M. A S Moore, Hal Broxmeyer, C. Cirrincione, B. Clarkson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

A simplified system for classification of aggregate incidence and growth pattern in the CFU-c (colony-forming units in culture) assay, allowing simple and reproducible interpretation of test results, was developed and applied to 552 bone marrow samples from 202 adult patients with acute leukemia. Ninety-six consecutive patients with acute nonlymphoblastic leukemia were studied at diagnosis. The microcluster growth pattern ('acute myeloid leukemia-type') found in 57% of the patients, was significantly associated with higher remission induction rates on both protocols (p=0.004). No relationship between growth pattern at diagnosis and remission duration was observed. The acute myeloid leukemia-type growth pattern was found to be more frequent in leukemias exhibiting morphological evidence for partial myeloid or monocytic differentiation. The favorable prognostic significance of Auer rods previously described was recognized in two CFU-c growth pattern categories. Of patients exhibiting an acute myeloid leukemia-growth pattern and Auer rods, 89% obtained complete remissions compared to 38% in the Auer rod-negative group showing other growth pattern variants. The CFU-c assays performed during complete remission on 354 samples of 48 patients with acute nonlymphoblastic leukemia and, as a control, on 85 samples of 43 patients with acute lymphoblastic leukemia revealed marked spontaneous as well as chemotherapy-related fluctuations of aggregate incidence and growth pattern. These and similar observations obtained with other assay systems are probably of major pathophysiological significance but preclude clinical application of the CFU-c assay to the monitoring of remission status in patients with acute nonlymphoblastic leukemia.

Original languageEnglish (US)
Pages (from-to)4844-4848
Number of pages5
JournalCancer Research
Volume41
Issue number11 II
StatePublished - 1981
Externally publishedYes

Fingerprint

Acute Myeloid Leukemia
Stem Cells
Growth
Leukemia
Remission Induction
Incidence
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Marrow
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mertelsmann, R., Moore, M. A. S., Broxmeyer, H., Cirrincione, C., & Clarkson, B. (1981). Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. Cancer Research, 41(11 II), 4844-4848.

Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. / Mertelsmann, R.; Moore, M. A S; Broxmeyer, Hal; Cirrincione, C.; Clarkson, B.

In: Cancer Research, Vol. 41, No. 11 II, 1981, p. 4844-4848.

Research output: Contribution to journalArticle

Mertelsmann, R, Moore, MAS, Broxmeyer, H, Cirrincione, C & Clarkson, B 1981, 'Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia', Cancer Research, vol. 41, no. 11 II, pp. 4844-4848.
Mertelsmann R, Moore MAS, Broxmeyer H, Cirrincione C, Clarkson B. Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. Cancer Research. 1981;41(11 II):4844-4848.
Mertelsmann, R. ; Moore, M. A S ; Broxmeyer, Hal ; Cirrincione, C. ; Clarkson, B. / Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. In: Cancer Research. 1981 ; Vol. 41, No. 11 II. pp. 4844-4848.
@article{370b23281b3141278f0723be9a28ae5e,
title = "Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia",
abstract = "A simplified system for classification of aggregate incidence and growth pattern in the CFU-c (colony-forming units in culture) assay, allowing simple and reproducible interpretation of test results, was developed and applied to 552 bone marrow samples from 202 adult patients with acute leukemia. Ninety-six consecutive patients with acute nonlymphoblastic leukemia were studied at diagnosis. The microcluster growth pattern ('acute myeloid leukemia-type') found in 57{\%} of the patients, was significantly associated with higher remission induction rates on both protocols (p=0.004). No relationship between growth pattern at diagnosis and remission duration was observed. The acute myeloid leukemia-type growth pattern was found to be more frequent in leukemias exhibiting morphological evidence for partial myeloid or monocytic differentiation. The favorable prognostic significance of Auer rods previously described was recognized in two CFU-c growth pattern categories. Of patients exhibiting an acute myeloid leukemia-growth pattern and Auer rods, 89{\%} obtained complete remissions compared to 38{\%} in the Auer rod-negative group showing other growth pattern variants. The CFU-c assays performed during complete remission on 354 samples of 48 patients with acute nonlymphoblastic leukemia and, as a control, on 85 samples of 43 patients with acute lymphoblastic leukemia revealed marked spontaneous as well as chemotherapy-related fluctuations of aggregate incidence and growth pattern. These and similar observations obtained with other assay systems are probably of major pathophysiological significance but preclude clinical application of the CFU-c assay to the monitoring of remission status in patients with acute nonlymphoblastic leukemia.",
author = "R. Mertelsmann and Moore, {M. A S} and Hal Broxmeyer and C. Cirrincione and B. Clarkson",
year = "1981",
language = "English (US)",
volume = "41",
pages = "4844--4848",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "11 II",

}

TY - JOUR

T1 - Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia

AU - Mertelsmann, R.

AU - Moore, M. A S

AU - Broxmeyer, Hal

AU - Cirrincione, C.

AU - Clarkson, B.

PY - 1981

Y1 - 1981

N2 - A simplified system for classification of aggregate incidence and growth pattern in the CFU-c (colony-forming units in culture) assay, allowing simple and reproducible interpretation of test results, was developed and applied to 552 bone marrow samples from 202 adult patients with acute leukemia. Ninety-six consecutive patients with acute nonlymphoblastic leukemia were studied at diagnosis. The microcluster growth pattern ('acute myeloid leukemia-type') found in 57% of the patients, was significantly associated with higher remission induction rates on both protocols (p=0.004). No relationship between growth pattern at diagnosis and remission duration was observed. The acute myeloid leukemia-type growth pattern was found to be more frequent in leukemias exhibiting morphological evidence for partial myeloid or monocytic differentiation. The favorable prognostic significance of Auer rods previously described was recognized in two CFU-c growth pattern categories. Of patients exhibiting an acute myeloid leukemia-growth pattern and Auer rods, 89% obtained complete remissions compared to 38% in the Auer rod-negative group showing other growth pattern variants. The CFU-c assays performed during complete remission on 354 samples of 48 patients with acute nonlymphoblastic leukemia and, as a control, on 85 samples of 43 patients with acute lymphoblastic leukemia revealed marked spontaneous as well as chemotherapy-related fluctuations of aggregate incidence and growth pattern. These and similar observations obtained with other assay systems are probably of major pathophysiological significance but preclude clinical application of the CFU-c assay to the monitoring of remission status in patients with acute nonlymphoblastic leukemia.

AB - A simplified system for classification of aggregate incidence and growth pattern in the CFU-c (colony-forming units in culture) assay, allowing simple and reproducible interpretation of test results, was developed and applied to 552 bone marrow samples from 202 adult patients with acute leukemia. Ninety-six consecutive patients with acute nonlymphoblastic leukemia were studied at diagnosis. The microcluster growth pattern ('acute myeloid leukemia-type') found in 57% of the patients, was significantly associated with higher remission induction rates on both protocols (p=0.004). No relationship between growth pattern at diagnosis and remission duration was observed. The acute myeloid leukemia-type growth pattern was found to be more frequent in leukemias exhibiting morphological evidence for partial myeloid or monocytic differentiation. The favorable prognostic significance of Auer rods previously described was recognized in two CFU-c growth pattern categories. Of patients exhibiting an acute myeloid leukemia-growth pattern and Auer rods, 89% obtained complete remissions compared to 38% in the Auer rod-negative group showing other growth pattern variants. The CFU-c assays performed during complete remission on 354 samples of 48 patients with acute nonlymphoblastic leukemia and, as a control, on 85 samples of 43 patients with acute lymphoblastic leukemia revealed marked spontaneous as well as chemotherapy-related fluctuations of aggregate incidence and growth pattern. These and similar observations obtained with other assay systems are probably of major pathophysiological significance but preclude clinical application of the CFU-c assay to the monitoring of remission status in patients with acute nonlymphoblastic leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0019777913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019777913&partnerID=8YFLogxK

M3 - Article

C2 - 6945907

AN - SCOPUS:0019777913

VL - 41

SP - 4844

EP - 4848

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 11 II

ER -